Khaitan & Co advised Indo Phyto Chemicals on the sale of 51 per cent stake in it to pharma company Sequent Scientific which was advised by Nishith Desai Associates (NDA).
Khaitan Delhi partner Bharat Anand, senior associate Tanvi Kumar and associate Vrinda Agarwal acted for Indo.
NDA Mumbai M&A co-head Simone Reis acted for Sequent.
The acquisition was for Rs 6.85 crore ($1m) and will help Sequent enter the female healthcare segment, according to VC Circle.
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
threads most popular
thread most upvoted
comment newest
first oldest
first
threads most popular
thread most upvoted
comment newest
first oldest
first